SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JACK SHOYKHET who wrote (491)3/16/1997 10:41:00 PM
From: Larry Liebman   of 6136
 
Went to hear Jim McCamant talk of and about biotechs on Saturday...He'll be selling a portion of his AGPH portfolio on Monday...But, before jumping to any conclusions, consider the rest...Apparently,in his last newsletter he committed to selling a percentage the day after approval was given for Viracept...What he believed was that the price would be(quote), "20 to 30 points higher..If I could undue my commitment to sell(said he), I would"...He stated that he believed that within 3-6 months Viracept would be the leading protease on the market...He continues to be highly positive towards AGPH...McCamant also mentioned Somatogen, Arris, and Isis, as stocks he would buy/hold for the long term...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext